CD8A and neoplasm: Previous studies reported that NKT cells mediate liver-selected tumor inhibition induced by the gut microbiome [33], and enhance antitumor immunity by reinvigorating exhausted CD8+ T cells in checkpoint inhibitor immunotherapy [34].